Keyphrases
Lung Cancer
100%
Pharmacologic
100%
Carboplatin
100%
Irinotecan
100%
Diarrhea
33%
Pharmacokinetic Parameters
33%
Neutropenia
33%
Maximum Tolerated Dose
33%
Interaction Terms
33%
Non-small Cell Lung Cancer (NSCLC)
16%
Neutrophil Count
16%
Confidence Interval
16%
Plasma Concentration
16%
Thrombocytopenia
16%
Pharmacokinetics
16%
High Risk
16%
Life-threatening
16%
Response Rate
16%
Recommended Dose
16%
Phase II Study
16%
Combination Chemotherapy
16%
Pharmacodynamics
16%
Small Cell Lung Cancer
16%
Platelet Count
16%
Pharmacokinetic Analysis
16%
Severe Diarrhea
16%
Severe Neutropenia
16%
Multivariate Regression Model
16%
Surviving Fraction
16%
Combination Regimen
16%
Dose-limiting Toxicity
16%
Dosing Schedule
16%
Pharmacodynamic Interactions
16%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Cancer
100%
Carboplatin
100%
Irinotecan
100%
Diarrhea
50%
Pharmacodynamics
50%
Neutropenia
50%
Pharmacokinetic Parameter
33%
Maximum Tolerated Dose
33%
Chemotherapy
16%
Small Cell Lung Cancer
16%
Non Small Cell Lung Cancer
16%
Thrombocytopenia
16%
Pharmacokinetics
16%